Feedback Regulations of miR-21 and MAPKs via Pdcd4 and Spry1 Are Involved in Arsenite-Induced Cell Malignant Transformation

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Shen, Lu ^a   Ling, Min ^a,c   Li, Yuan ^a   Xu, Yuan ^a   Zhou, Yun ^b   Ye, Jing ^b   Pang, Ying ^a   Zhao, Yue ^a   Jiang, Rongrong ^a   Zhang, Jianping ^b   Liu, Qizhan ^a  

^a BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^b THE SECOND AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^c JIANGSU PROVINCIAL CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC TRIOXIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MICRORNA 21; MITOGEN ACTIVATED PROTEIN KINASE; PROGRAMMED CELL DEATH PROTEIN 4; SMALL INTERFERING RNA; SPRY1 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL GROWTH; CELL MIGRATION; CLONOGENESIS; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; ENZYME ACTIVATION; FEEDBACK SYSTEM; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN EMBRYO LUNG FIBROBLAST; IMMUNOFLUORESCENCE; LUNG FIBROBLAST; MALIGNANT TRANSFORMATION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STAINING; UPREGULATION; WESTERN BLOTTING; WOUND HEALING;

APOPTOSIS REGULATORY PROTEINS; ARSENITES; CELL LINE, TRANSFORMED; CELL MOVEMENT; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; EMBRYO, MAMMALIAN; FEEDBACK, PHYSIOLOGICAL; FIBROBLASTS; GENE EXPRESSION REGULATION; HUMANS; MAP KINASE KINASE 4; MEMBRANE PROTEINS; MICRORNAS; NF-KAPPA B; PHOSPHOPROTEINS; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-JUN; RNA, SMALL INTERFERING; RNA-BINDING PROTEINS; SIGNAL TRANSDUCTION;

EID: 84874572210     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0057652     Document Type: Article

References (65)

1. Li G, Lee LS, Li M, Tsao SW, Chiu JF, (2011) Molecular changes during arsenic-induced cell transformation. J Cell Physiol 226: 3225-3232.
2. Li Y, Shen L, Xu H, Pang Y, Xu Y, et al. (2011) Up-regulation of cyclin D1 by JNK1/c-Jun is involved in tumorigenesis of human embryo lung fibroblast cells induced by a low concentration of arsenite. Toxicol Lett 206: 113-120.
3. Ouyang W, Li J, Ma Q, Huang C, (2006) Essential roles of PI-3K/Akt/IKKbeta/NFkappaB pathway in cyclin D1 induction by arsenite in JB6 Cl41 cells. Carcinogenesis 27: 864-873.
4. Carpenter RL, Jiang Y, Jing Y, He J, Rojanasakul Y, et al. (2011) Arsenite induces cell transformation by reactive oxygen species, AKT, ERK1/2, and p70S6K1. Biochem Biophys Res Commun 414: 533-538.
5. IARC (2004) Some drinking-water disinfectants and contaminants, including arsenic. IARC Monogr Eval Carcinog Risks Hum 84: 1-477.
6. Heck JE, Andrew AS, Onega T, Rigas JR, Jackson BP, et al. (2009) Lung cancer in a U.S. population with low to moderate arsenic exposure. Environ Health Perspect 117: 1718-1723.
7. Bartel DP, (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
8. Ma X, Kumar M, Choudhury SN, Becker Buscaglia LE, Barker JR, et al. (2011) Loss of the miR-21 allele elevates the expression of its target genes and reduces tumorigenesis. Proc Natl Acad Sci U S A 108: 10144-10149.
9. Alder H, Taccioli C, Chen H, Jiang Y, Smalley KJ, et al. (2012) Dysregulation of miR-31 and miR-21 induced by zinc deficiency promotes esophageal cancer. Carcinogenesis. 33: 1736-1744.
10. Lee JH, Voortman J, Dingemans AM, Voeller DM, Pham T, et al. (2011) MicroRNA expression and clinical outcome of small cell lung cancer. PLoS One 6: e21300.
11. Grunder E, D'Ambrosio R, Fiaschetti G, Abela L, Arcaro A, et al. (2011) MicroRNA-21 suppression impedes medulloblastoma cell migration. Eur J Cancer 47: 2479-2490.
12. Schramedei K, Morbt N, Pfeifer G, Lauter J, Rosolowski M, et al. (2011) MicroRNA-21 targets tumor suppressor genes ANP32A and SMARCA4. Oncogene 30: 2975-2985.
13. Ling M, Li Y, Xu Y, Pang Y, Shen L, et al. (2012) Regulation of miRNA-21 by reactive oxygen species-activated ERK/NF-kappaB in arsenite-induced cell transformation. Free Radic Biol Med 52: 1508-1518.
14. Fischer N, Goke F, Splittstosser V, Lankat-Buttgereit B, Muller SC, et al. (2012) Expression of programmed cell death protein 4 (PDCD4) and miR-21 in urothelial carcinoma. Biochem Biophys Res Commun 417: 29-34.
15. Narasimhan M, Rathinam M, Riar A, Patel D, Mummidi S, et al. (2012) Programmed Cell Death 4 (PDCD4): A novel player in ethanol-mediated suppression of protein translation in primary cortical neurons and developing cerebral cortex. Alcohol Clin Exp Res 37(1): 96-109.
16. Jansen AP, Camalier CE, Colburn NH, (2005) Epidermal expression of the translation inhibitor programmed cell death 4 suppresses tumorigenesis. Cancer Res 65: 6034-6041.
17. Leupold JH, Yang HS, Colburn NH, Asangani I, Post S, et al. (2007) Tumor suppressor Pdcd4 inhibits invasion/intravasation and regulates urokinase receptor (u-PAR) gene expression via Sp-transcription factors. Oncogene 26: 4550-4562.
18. Gaur AB, Holbeck SL, Colburn NH, Israel MA, (2011) Downregulation of Pdcd4 by mir-21 facilitates glioblastoma proliferation in vivo. Neuro Oncol 13: 580-590.
19. Talotta F, Cimmino A, Matarazzo MR, Casalino L, De Vita G, et al. (2009) An autoregulatory loop mediated by miR-21 and PDCD4 controls the AP-1 activity in RAS transformation. Oncogene 28: 73-84.
20. Wang Q, Sun Z, Yang HS, (2008) Downregulation of tumor suppressor Pdcd4 promotes invasion and activates both beta-catenin/Tcf and AP-1-dependent transcription in colon carcinoma cells. Oncogene 27: 1527-1535.
21. Wang Q, Zhang Y, Yang HS, (2012) Pdcd4 knockdown up-regulates MAP4K1 expression and activation of AP-1 dependent transcription through c-Myc. Biochim Biophys Acta 1823: 1807-1814.
22. Zhu Q, Wang Z, Hu Y, Li J, Li X, et al. (2012) miR-21 promotes migration and invasion by the miR-21-PDCD4-AP-1 feedback loop in human hepatocellular carcinoma. Oncol Rep 27: 1660-1668.
23. Bitomsky N, Bohm M, Klempnauer KH, (2004) Transformation suppressor protein Pdcd4 interferes with JNK-mediated phosphorylation of c-Jun and recruitment of the coactivator p300 by c-Jun. Oncogene 23: 7484-7493.
24. Yang HS, Matthews CP, Clair T, Wang Q, Baker AR, et al. (2006) Tumorigenesis suppressor Pdcd4 down-regulates mitogen-activated protein kinase kinase kinase kinase 1 expression to suppress colon carcinoma cell invasion. Mol Cell Biol 26: 1297-1306.
25. Schaaf G, Hamdi M, Zwijnenburg D, Lakeman A, Geerts D, et al. (2010) Silencing of SPRY1 triggers complete regression of rhabdomyosarcoma tumors carrying a mutated RAS gene. Cancer Res 70: 762-771.
26. Moghaddam SM, Amini A, Wei AQ, Pourgholami MH, Morris DL, (2012) Initial report on differential expression of sprouty proteins 1 and 2 in human epithelial ovarian cancer cell lines. J Oncol 2012: 373826.
27. Lo TL, Yusoff P, Fong CW, Guo K, McCaw BJ, et al. (2004) The ras/mitogen-activated protein kinase pathway inhibitor and likely tumor suppressor proteins, sprouty 1 and sprouty 2 are deregulated in breast cancer. Cancer Res 64: 6127-6136.
28. Shin EH, Basson MA, Robinson ML, McAvoy JW, Lovicu FJ, (2012) Sprouty Is a Negative Regulator of Transforming Growth Factor beta-Induced Epithelial-to-Mesenchymal Transition and Cataract. Mol Med 18: 861-873.
29. Chen B, Liu J, Chang Q, Beezhold K, Lu Y, et al. (2012) JNK and STAT3 signaling pathways converge on Akt-mediated phosphorylation of EZH2 in bronchial epithelial cells induced by arsenic. Cell Cycle 12(1): 112-121.
30. Macia A, Gallel P, Vaquero M, Gou-Fabregas M, Santacana M, et al. (2011) Sprouty1 is a candidate tumor-suppressor gene in medullary thyroid carcinoma. Oncogene 31: 3961-3972.
31. Thum T, Gross C, Fiedler J, Fischer T, Kissler S, et al. (2008) MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 456: 980-984.
32. Sabatel C, Cornet AM, Tabruyn SP, Malvaux L, Castermans K, et al. (2010) Sprouty1, a new target of the angiostatic agent 16K prolactin, negatively regulates angiogenesis. Mol Cancer 9: 231.
33. Hayflick L, Moorhead PS, (1961) The serial cultivation of human diploid cell strains. Exp Cell Res 25: 585-621.
34. Gao A, Liu B, Shi X, Jia X, Ye M, et al. (2007) Phosphatidylinositol-3 kinase/Akt/p70S6K/AP-1 signaling pathway mediated benzo(a)pyrene-induced cell cycle alternation via cell cycle regulatory proteins in human embryo lung fibroblasts. Toxicol Lett 170: 30-41.
35. Wang J, Ouyang W, Li J, Wei L, Ma Q, et al. (2005) Loss of tumor suppressor p53 decreases PTEN expression and enhances signaling pathways leading to activation of activator protein 1 and nuclear factor kappaB induced by UV radiation. Cancer Res 65: 6601-6611.
36. Li Y, Xu Y, Ling M, Yang Y, Wang S, et al. (2010) mot-2-Mediated cross talk between nuclear factor-B and p53 is involved in arsenite-induced tumorigenesis of human embryo lung fibroblast cells. Environ Health Perspect 118: 936-942.
37. Frankel LB, Christoffersen NR, Jacobsen A, Lindow M, Krogh A, et al. (2008) Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J Biol Chem 283: 1026-1033.
38. Kwak HJ, Kim YJ, Chun KR, Woo YM, Park SJ, et al. (2011) Downregulation of Spry2 by miR-21 triggers malignancy in human gliomas. Oncogene 30: 2433-2442.
39. Guo X, Li W, Wang Q, Yang HS, (2011) AKT Activation by Pdcd4 Knockdown Up-Regulates Cyclin D1 Expression and Promotes Cell Proliferation. Genes Cancer 2: 818-828.
40. Cantor KP, Lubin JH, (2007) Arsenic, internal cancers, and issues in inference from studies of low-level exposures in human populations. Toxicol Appl Pharmacol 222: 252-257.
41. Huang C, Ke Q, Costa M, Shi X, (2004) Molecular mechanisms of arsenic carcinogenesis. Mol Cell Biochem 255: 57-66.
42. Wang Z, Yang J, Fisher T, Xiao H, Jiang Y, et al. (2012) Akt activation is responsible for enhanced migratory and invasive behavior of arsenic-transformed human bronchial epithelial cells. Environ Health Perspect 120: 92-97.
43. Huang C, Li J, Ding M, Wang L, Shi X, et al. (2001) Arsenic-induced NFkappaB transactivation through Erks- and JNKs-dependent pathways in mouse epidermal JB6 cells. Mol Cell Biochem 222: 29-34.
44. He XQ, Chen R, Yang P, Li AP, Zhou JW, et al. (2007) Biphasic effect of arsenite on cell proliferation and apoptosis is associated with the activation of JNK and ERK1/2 in human embryo lung fibroblast cells. Toxicol Appl Pharmacol 220: 18-24.
45. Jiang Y, Wu Y, Greenlee AR, Wu J, Han Z, et al. (2011) miR-106a-mediated malignant transformation of cells induced by anti-benzo[a]pyrene-trans-7,8-diol-9,10-epoxide. Toxicol Sci 119: 50-60.
46. Izzotti A, Calin GA, Arrigo P, Steele VE, Croce CM, et al. (2009) Downregulation of microRNA expression in the lungs of rats exposed to cigarette smoke. FASEB J 23: 806-812.
47. Zhang JG, Wang JJ, Zhao F, Liu Q, Jiang K, et al. (2010) MicroRNA-21 (miR-21) represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer (NSCLC). Clin Chim Acta 411: 846-852.
48. Frezzetti D, De Menna M, Zoppoli P, Guerra C, Ferraro A, et al. (2011) Upregulation of miR-21 by Ras in vivo and its role in tumor growth. Oncogene 30: 275-286.
49. Hatley ME, Patrick DM, Garcia MR, Richardson JA, Bassel-Duby R, et al. (2010) Modulation of K-Ras-dependent lung tumorigenesis by MicroRNA-21. Cancer Cell 18: 282-293.
50. Loayza-Puch F, Yoshida Y, Matsuzaki T, Takahashi C, Kitayama H, et al. (2010) Hypoxia and RAS-signaling pathways converge on, and cooperatively downregulate, the RECK tumor-suppressor protein through microRNAs. Oncogene 29: 2638-2648.
51. Miller KA, Yeager N, Baker K, Liao XH, Refetoff S, et al. (2009) Oncogenic Kras requires simultaneous PI3K signaling to induce ERK activation and transform thyroid epithelial cells in vivo. Cancer Res 69: 3689-3694.
52. Darido C, Georgy SR, Wilanowski T, Dworkin S, Auden A, et al. (2011) Targeting of the tumor suppressor GRHL3 by a miR-21-dependent proto-oncogenic network results in PTEN loss and tumorigenesis. Cancer Cell 20: 635-648.
53. Loffler D, Brocke-Heidrich K, Pfeifer G, Stocsits C, Hackermuller J, et al. (2007) Interleukin-6 dependent survival of multiple myeloma cells involves the Stat3-mediated induction of microRNA-21 through a highly conserved enhancer. Blood 110: 1330-1333.
54. Han L, Yue X, Zhou X, Lan FM, You G, et al. (2012) MicroRNA-21 expression is regulated by beta-catenin/STAT3 pathway and promotes glioma cell invasion by direct targeting RECK. CNS Neurosci Ther 18: 573-583.
55. Niu J, Shi Y, Tan G, Yang CH, Fan M, et al. (2012) DNA damage induces NF-kappaB-dependent microRNA-21 up-regulation and promotes breast cancer cell invasion. J Biol Chem 287: 21783-21795.
56. Galardi S, Mercatelli N, Farace MG, Ciafre SA, (2011) NF-kB and c-Jun induce the expression of the oncogenic miR-221 and miR-222 in prostate carcinoma and glioblastoma cells. Nucleic Acids Res 39: 3892-3902.
57. Shin VY, Jin H, Ng EK, Cheng AS, Chong WW, et al. (2011) NF-kappaB targets miR-16 and miR-21 in gastric cancer: involvement of prostaglandin E receptors. Carcinogenesis 32: 240-245.
58. Chen Y, Liu W, Chao T, Zhang Y, Yan X, et al. (2008) MicroRNA-21 down-regulates the expression of tumor suppressor PDCD4 in human glioblastoma cell T98G. Cancer Lett 272: 197-205.
59. Itani S, Kunisada T, Morimoto Y, Yoshida A, Sasaki T, et al. (2012) MicroRNA-21 correlates with tumorigenesis in malignant peripheral nerve sheath tumor (MPNST) via programmed cell death protein 4 (PDCD4). J Cancer Res Clin Oncol 138(9): 1501-9.
60. Asangani IA, Rasheed SA, Nikolova DA, Leupold JH, Colburn NH, et al. (2008) MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 27: 2128-2136.
61. Yang HS, Knies JL, Stark C, Colburn NH, (2003) Pdcd4 suppresses tumor phenotype in JB6 cells by inhibiting AP-1 transactivation. Oncogene 22: 3712-3720.
62. Sutterluty H, Mayer CE, Setinek U, Attems J, Ovtcharov S, et al. (2007) Down-regulation of Sprouty2 in non-small cell lung cancer contributes to tumor malignancy via extracellular signal-regulated kinase pathway-dependent and-independent mechanisms. Mol Cancer Res 5: 509-520.
63. Papagiannakopoulos T, Shapiro A, Kosik KS, (2008) MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells. Cancer Res 68: 8164-8172.
64. Liu L, Jiang Y, Zhang H, Greenlee AR, Yu R, et al. (2010) miR-22 functions as a micro-oncogene in transformed human bronchial epithelial cells induced by anti-benzo[a]pyrene-7,8-diol-9,10-epoxide. Toxicol In Vitro 24: 1168-1175.
65. Rettig M, Trinidad K, Pezeshkpour G, Frost P, Sharma S, et al. (2012) PAK1 Kinase Promotes Cell Motility and Invasiveness through CRK-II Serine Phosphorylation in Non-Small Cell Lung Cancer Cells. PLoS One 7: e42012.